Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Capricor Therapeutics (CAPR) Return on Equity (2016 - 2025)

Historic Return on Equity for Capricor Therapeutics (CAPR) over the last 15 years, with Q3 2025 value amounting to 0.61%.

  • Capricor Therapeutics' Return on Equity rose 2500.0% to 0.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61%, marking a year-over-year increase of 2500.0%. This contributed to the annual value of 0.48% for FY2024, which is 8200.0% up from last year.
  • As of Q3 2025, Capricor Therapeutics' Return on Equity stood at 0.61%, which was up 2500.0% from 0.39% recorded in Q2 2025.
  • Capricor Therapeutics' Return on Equity's 5-year high stood at 0.22% during Q1 2025, with a 5-year trough of 61.91% in Q3 2023.
  • In the last 5 years, Capricor Therapeutics' Return on Equity had a median value of 0.61% in 2021 and averaged 4.4%.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -611700bps in 2023, then surged by 610500bps in 2024.
  • Capricor Therapeutics' Return on Equity (Quarter) stood at 0.61% in 2021, then plummeted by -68bps to 1.03% in 2022, then crashed by -108bps to 2.15% in 2023, then soared by 82bps to 0.38% in 2024, then tumbled by -61bps to 0.61% in 2025.
  • Its last three reported values are 0.61% in Q3 2025, 0.39% for Q2 2025, and 0.22% during Q1 2025.